Skip to main content
Erschienen in: Rheumatology International 4/2005

01.05.2005 | Original Article

Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis

verfasst von: Veli Çobankara, Mehmet Akif Öztürk, Sedat Kiraz, Ihsan Ertenli, Ibrahim C. Haznedaroglu, Salih Pay, Meral Çalgüneri

Erschienen in: Rheumatology International | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Local functional renin-angiotensin systems (RAS) have been demonstrated in many organ and tissue systems. Angiotensins, the effector growth factors of the RAS, are essentially cytokines and growth factors which actively contribute to many inflammatory reactions. Among the components of RAS, angiotensin-converting enzyme (ACE) and renin have been previously investigated separately in RA. In this study, ACE levels and renin concentrations were measured in the sera of 16 patients with RA (median age: 45 (26–69), male/female: 3/13), 13 patients with osteoarthritis (OA) (median age: 55 (28–72), male/female: 5/8), and 11 healthy adults (median age: 44 (35–70), male/female: 6/5). Synovial ACE levels and renin concentrations were also measured concurrently in patients with RA and OA. Serum ACE levels were comparable between the groups. However, synovial fluid ACE levels were significantly higher in the patients with RA than in patients with OA. Likewise, synovial fluid renin concentrations were higher in RA patients than in OA patients, while serum renin concentrations were similar in patients with RA and OA and in healthy controls. Moreover, there was a significant negative correlation between the duration of the disease and synovial renin concentrations in RA patients. In conclusion, locally-generated active renin and ACE could contribute to joint destruction in rheumatoid arthritis.
Literatur
1.
Zurück zum Zitat Stuhlmuller B, Ungethum U, Scholze S, Martinez L, Backhaus M, Kraetsch HG, Kinne RW, Burmester GR (2000) Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. Arthritis Rheum 43:775–790CrossRef Stuhlmuller B, Ungethum U, Scholze S, Martinez L, Backhaus M, Kraetsch HG, Kinne RW, Burmester GR (2000) Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. Arthritis Rheum 43:775–790CrossRef
2.
Zurück zum Zitat Kenny TP, Leider P, Duong PA, Robbins DL (1996) Antigen binding differences between secreted and cell surface expressed rheumatoid factor derived from inflamed synovium. J Rheumatol 23:819–825 Kenny TP, Leider P, Duong PA, Robbins DL (1996) Antigen binding differences between secreted and cell surface expressed rheumatoid factor derived from inflamed synovium. J Rheumatol 23:819–825
3.
Zurück zum Zitat Walsh DA, Mapp PI, Wharton J, Polak JM, Blake DR (1993) Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 142:1610–1621 Walsh DA, Mapp PI, Wharton J, Polak JM, Blake DR (1993) Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 142:1610–1621
4.
Zurück zum Zitat Matucci-Cerinic M, Lombardi A, Leoncini G, Pignone A, Sacerdoti L, Spillantini MG, Partsch G (1993) Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation? Rheumatol Int 13:1–4CrossRef Matucci-Cerinic M, Lombardi A, Leoncini G, Pignone A, Sacerdoti L, Spillantini MG, Partsch G (1993) Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation? Rheumatol Int 13:1–4CrossRef
5.
Zurück zum Zitat Lerner UH, Jones IL, Gustafson GT (1987) Bradykinin, a new potential mediator of inflammation-induced bone resorption. Studies of the effects on mouse calvarial bones and articular cartilage in vitro. Arthritis Rheum 30:530–540 Lerner UH, Jones IL, Gustafson GT (1987) Bradykinin, a new potential mediator of inflammation-induced bone resorption. Studies of the effects on mouse calvarial bones and articular cartilage in vitro. Arthritis Rheum 30:530–540
6.
Zurück zum Zitat Sheikh IA, Kaplan AP (1987) Assessment of kininases in rheumatic diseases and the effect of therapeutic agents. Arthritis Rheum 30:138–145 Sheikh IA, Kaplan AP (1987) Assessment of kininases in rheumatic diseases and the effect of therapeutic agents. Arthritis Rheum 30:138–145
7.
Zurück zum Zitat Haznedaroglu IC, Ozturk MA (2003) Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 35:867–880CrossRef Haznedaroglu IC, Ozturk MA (2003) Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 35:867–880CrossRef
8.
Zurück zum Zitat Re RN (2004) Tissue renin angiotensin systems. Med Clin North Am 88:19–38 Re RN (2004) Tissue renin angiotensin systems. Med Clin North Am 88:19–38
9.
Zurück zum Zitat Hoj NA, Knudsen F (1987) Angiotensinogen is an acute-phase protein in man. Scand J Clin Lab Invest 47:175–178 Hoj NA, Knudsen F (1987) Angiotensinogen is an acute-phase protein in man. Scand J Clin Lab Invest 47:175–178
10.
Zurück zum Zitat Phillips MI, Kagiyama S (2002) Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 3:569–577 Phillips MI, Kagiyama S (2002) Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 3:569–577
11.
Zurück zum Zitat Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J (2001) Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10:321–329CrossRef Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J (2001) Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10:321–329CrossRef
12.
Zurück zum Zitat Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35:881–900CrossRef Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35:881–900CrossRef
13.
Zurück zum Zitat Goto M, Fujisawa M, Yamada A, Okabe T, Takaku F, Sasano M, Nishioka K (1990) Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition. Ann Rheum Dis 49:172–176 Goto M, Fujisawa M, Yamada A, Okabe T, Takaku F, Sasano M, Nishioka K (1990) Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition. Ann Rheum Dis 49:172–176
14.
Zurück zum Zitat Machin ND, Chard MD, Paice EW (1984) Serum angiotensin converting enzyme in Sjogren’s syndrome–a case report and study of 21 further cases. Postgrad Med J 60:270–271 Machin ND, Chard MD, Paice EW (1984) Serum angiotensin converting enzyme in Sjogren’s syndrome–a case report and study of 21 further cases. Postgrad Med J 60:270–271
15.
Zurück zum Zitat Boers M, Breedveld FC, Dijkmans BA, Chang PC, van Brummelen P, Derkx FH, Cats A (1990) Raised plasma renin and prorenin in rheumatoid vasculitis. Ann Rheum Dis 49:517–520 Boers M, Breedveld FC, Dijkmans BA, Chang PC, van Brummelen P, Derkx FH, Cats A (1990) Raised plasma renin and prorenin in rheumatoid vasculitis. Ann Rheum Dis 49:517–520
16.
Zurück zum Zitat Lowe JR, Dixon JS, Guthrie JA, McWhinney P (1986) Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis. Ann Rheum Dis 45:921–924 Lowe JR, Dixon JS, Guthrie JA, McWhinney P (1986) Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis. Ann Rheum Dis 45:921–924
17.
Zurück zum Zitat Veale D, Yanni G, Bresnihan B, FitzGerald O (1992) Production of angiotensin converting enzyme by rheumatoid synovial membrane. Ann Rheum Dis 51:476–480 Veale D, Yanni G, Bresnihan B, FitzGerald O (1992) Production of angiotensin converting enzyme by rheumatoid synovial membrane. Ann Rheum Dis 51:476–480
18.
Zurück zum Zitat Izai M, Miyazaki S, Murai R, Morioka Y, Hayashi H, Nishiura M, Miura K (1992) Prorenin-renin axis in synovial fluid in patients with rheumatoid arthritis and osteoarthritis. Endocrinol Jpn 39:259–267 Izai M, Miyazaki S, Murai R, Morioka Y, Hayashi H, Nishiura M, Miura K (1992) Prorenin-renin axis in synovial fluid in patients with rheumatoid arthritis and osteoarthritis. Endocrinol Jpn 39:259–267
19.
Zurück zum Zitat Bird HA, Le Gallez P, Dixon JS, Catalano MA, Traficante A, Liauw LA, Sussman H, Rotman H, Wright V (1990) A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis. J Rheumatol 17:603–608 Bird HA, Le Gallez P, Dixon JS, Catalano MA, Traficante A, Liauw LA, Sussman H, Rotman H, Wright V (1990) A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis. J Rheumatol 17:603–608
20.
Zurück zum Zitat Traficante A, Catalano MA, Ehrlich GE (1985) Angiotensin converting enzyme inhibitors and rheumatoid arthritis. Arthritis Rheum 28:480 Traficante A, Catalano MA, Ehrlich GE (1985) Angiotensin converting enzyme inhibitors and rheumatoid arthritis. Arthritis Rheum 28:480
21.
Zurück zum Zitat Martin MF, Surrall KE, McKenna F, Dixon JS, Bird HA, Wright V (1984) Captopril: a new treatment for rheumatoid arthritis? Lancet 1:1325–1328 Martin MF, Surrall KE, McKenna F, Dixon JS, Bird HA, Wright V (1984) Captopril: a new treatment for rheumatoid arthritis? Lancet 1:1325–1328
22.
Zurück zum Zitat Jaffe I (1984) Angiotensin converting inhibitors in rheumatoid arthritis. Arthritis Rheum 27:840 Jaffe I (1984) Angiotensin converting inhibitors in rheumatoid arthritis. Arthritis Rheum 27:840
23.
Zurück zum Zitat Holmquist B, Bunning P, Riordan JF (1979) A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 95:540–548CrossRef Holmquist B, Bunning P, Riordan JF (1979) A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 95:540–548CrossRef
24.
Zurück zum Zitat Miles LE (1975) Properties, variants, and applications of the immunoradiometric assay method. Ric Clin Lab 5:59–72 Miles LE (1975) Properties, variants, and applications of the immunoradiometric assay method. Ric Clin Lab 5:59–72
25.
Zurück zum Zitat Sato H, Watanabe A, Tanaka T, Koitabashi N, Arai M, Kurabayashi M, Yokoyama T (2003) Regulation of the human tumor necrosis factor-alpha promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors. J Mol Cell Cardiol 35:1197–1205CrossRef Sato H, Watanabe A, Tanaka T, Koitabashi N, Arai M, Kurabayashi M, Yokoyama T (2003) Regulation of the human tumor necrosis factor-alpha promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors. J Mol Cell Cardiol 35:1197–1205CrossRef
26.
Zurück zum Zitat Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T (1999) Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. Cytokine 11:759–765CrossRef Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T (1999) Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. Cytokine 11:759–765CrossRef
27.
Zurück zum Zitat Kranzhofer R, Browatzki M, Schmidt J, Kubler W (1999) Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes. Biochem Biophys Res Commun 257:826–828CrossRef Kranzhofer R, Browatzki M, Schmidt J, Kubler W (1999) Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes. Biochem Biophys Res Commun 257:826–828CrossRef
28.
Zurück zum Zitat Suzuki Y, Ruiz-Ortega M, Egido J (2000) Angiotensin II: a double-edged sword in inflammation. J Nephrol 13(Suppl 3):S101–S110 Suzuki Y, Ruiz-Ortega M, Egido J (2000) Angiotensin II: a double-edged sword in inflammation. J Nephrol 13(Suppl 3):S101–S110
29.
Zurück zum Zitat Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M (2003) Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J 17:2061–2067CrossRef Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M (2003) Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J 17:2061–2067CrossRef
30.
Zurück zum Zitat Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903–911CrossRef Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903–911CrossRef
31.
Zurück zum Zitat Walsh DA, Suzuki T, Knock GA, Blake DR, Polak JM, Wharton J (1994) AT1 receptor characteristics of angiotensin analogue binding in human synovium. Br J Pharmacol 112:435–442 Walsh DA, Suzuki T, Knock GA, Blake DR, Polak JM, Wharton J (1994) AT1 receptor characteristics of angiotensin analogue binding in human synovium. Br J Pharmacol 112:435–442
32.
Zurück zum Zitat Whitebread S, Mele M, Kamber B, de Gasparo M (1989) Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163:284–291CrossRef Whitebread S, Mele M, Kamber B, de Gasparo M (1989) Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163:284–291CrossRef
33.
Zurück zum Zitat Patel JM, Yarid FR, Block ER, Raizada MK (1989) Angiotensin receptors in pulmonary arterial and aortic endothelial cells. Am J Physiol 256:C987–C993 Patel JM, Yarid FR, Block ER, Raizada MK (1989) Angiotensin receptors in pulmonary arterial and aortic endothelial cells. Am J Physiol 256:C987–C993
34.
Zurück zum Zitat Thomas DW, Hoffman MD (1984) Identification of macrophage receptors for angiotensin: a potential role in antigen uptake for T lymphocyte responses? J Immunol 132:2807–2812 Thomas DW, Hoffman MD (1984) Identification of macrophage receptors for angiotensin: a potential role in antigen uptake for T lymphocyte responses? J Immunol 132:2807–2812
35.
Zurück zum Zitat Millan MA, Carvallo P, Izumi S, Zemel S, Catt KJ, Aguilera G (1989) Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244:1340–1342PubMed Millan MA, Carvallo P, Izumi S, Zemel S, Catt KJ, Aguilera G (1989) Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244:1340–1342PubMed
36.
Zurück zum Zitat Aoyagi T, Wada T, Tanaka T, Tanimoto K, Aikawa T, Hara T, Umeda T, Niijima T, Umezawa H (1984) Decreased serum levels of various hydrolytic enzymes in patients with rheumatoid arthritis. Biochem Int 8:529–535 Aoyagi T, Wada T, Tanaka T, Tanimoto K, Aikawa T, Hara T, Umeda T, Niijima T, Umezawa H (1984) Decreased serum levels of various hydrolytic enzymes in patients with rheumatoid arthritis. Biochem Int 8:529–535
37.
Zurück zum Zitat Walsh DA, Catravas J, Wharton J (2000) Angiotensin converting enzyme in human synovium: increased stromal [(125)I]351A binding in rheumatoid arthritis. Ann Rheum Dis 59:125–131CrossRef Walsh DA, Catravas J, Wharton J (2000) Angiotensin converting enzyme in human synovium: increased stromal [(125)I]351A binding in rheumatoid arthritis. Ann Rheum Dis 59:125–131CrossRef
38.
Zurück zum Zitat Soderblom T, Nyberg P, Pettersson T, Klockars M, Riska H (1996) Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis. Respiration 63:272–276 Soderblom T, Nyberg P, Pettersson T, Klockars M, Riska H (1996) Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis. Respiration 63:272–276
39.
Zurück zum Zitat Bhoola KD, Elson CJ, Dieppe PA (1992) Kinins–key mediators in inflammatory arthritis? Br J Rheumatol 31:509–518 Bhoola KD, Elson CJ, Dieppe PA (1992) Kinins–key mediators in inflammatory arthritis? Br J Rheumatol 31:509–518
40.
Zurück zum Zitat Mavrikakis ME, Vaiopoulos G, Papantoniou B, Antoniades LG, Kostopoulos C, Papazoglou S, Lianos EA (1996) Plasma renin activity as a marker of renovascular injury in patients with rheumatoid arthritis. Clin Exp Rheumatol 14:613–617 Mavrikakis ME, Vaiopoulos G, Papantoniou B, Antoniades LG, Kostopoulos C, Papazoglou S, Lianos EA (1996) Plasma renin activity as a marker of renovascular injury in patients with rheumatoid arthritis. Clin Exp Rheumatol 14:613–617
Metadaten
Titel
Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis
verfasst von
Veli Çobankara
Mehmet Akif Öztürk
Sedat Kiraz
Ihsan Ertenli
Ibrahim C. Haznedaroglu
Salih Pay
Meral Çalgüneri
Publikationsdatum
01.05.2005
Erschienen in
Rheumatology International / Ausgabe 4/2005
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0564-8

Weitere Artikel der Ausgabe 4/2005

Rheumatology International 4/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.